 |
|
Experimental flu vaccine appears promising in early tests
April 11, 2007An influenza vaccine produced with the use of insect cells appeared safe and produced an immunogenic response in healthy adults, suggesting promise as an alternative to using embryonated eggs for the development of influenza vaccine, according to a preliminary study in the April 11 issue of JAMA.
"All currently licensed influenza vaccines in the United States are produced in embryonated hen's eggs. There are several well-recognized disadvantages to the use of eggs as the substrate [the base on which an organism lives or grows] for influenza vaccine. Eggs require specialized manufacturing facilities and could be difficult to scale up rapidly in response to an emerging need such as a pandemic," the authors write. They add that development of alternative substrates for influenza vaccine production has been identified as a high-priority. One potential alternative is use of the influenza virus hemagglutinin (HA; an antibody that causes red blood cells to clump together) using recombinant (genetic recombination) DNA techniques.
John J. Treanor, M.D., of the University of Rochester, N.Y., and colleagues evaluated an experimental influenza vaccine consisting of recombinant HA expressed in insect cells by a recombinant baculovirus (rHA0). The clinical trial was conducted at three U.S. academic medical centers during the 2004-2005 influenza season and included 460 healthy adults. Participants were randomly assigned to receive a single injection of saline placebo (n = 154); 75 µg of an rHA0 vaccine containing 15 µg of hemagglutinin from influenza A/New Caledonia/20/99(H1N1) and influenza B/Jiangsu/10/03 virus and 45 µg of hemagglutinin from influenza A/Wyoming/3/03 (H3N2) virus (n = 153); or 135 µg of rHA0 containing 45 µg of hemagglutinin each from all 3 components (n = 153). Serum samples were taken before and 30 days following immunization.
The researchers found: "We have shown that the rHA0 vaccine is well tolerated in healthy adults and immunogenic at both doses evaluated, and we obtained preliminary evidence of protection against influenza infection and disease. The safety data generated in this study are consistent with the safety profile observed in previous studies of rHA0 vaccine. These vaccines have been well tolerated at all doses administered and are associated with low rates of local reactions."
"The use of recombinant DNA techniques to express proteins in cell culture has been a successful approach for generation of highly effective vaccines for the prevention of hepatitis B virus and human papillomavirus. Among the available expression technologies, recombinant baculovirus is especially well suited for production of influenza vaccine because the rapidity with which genes can be cloned and inserted into this vector facilitates updating the vaccine at regular intervals. In addition, the extraordinarily high yields of protein possible in this system provide the opportunity to use much higher and potentially more effective doses of vaccine. Expression of the HA protein in insect cells using recombinant baculovirus also avoids the need to work with potentially pathogenic live influenza viruses and the attendant biocontainment issues that would be a particular concern for generation of pandemic vaccines. The preliminary demonstration of protective efficacy in adults provides further support for the development of this promising approach for prevention of seasonal and pandemic influenza," the authors conclude.
JAMA and Archives Journals
The researchers found: "We have shown that the rHA0 vaccine is well tolerated in healthy adults and immunogenic at both doses evaluated, and we obtained preliminary evidence of protection against influenza infection and disease. The safety data generated in this study are consistent with the safety profile observed in previous studies of rHA0 vaccine. These vaccines have been well tolerated at all doses administered and are associated with low rates of local reactions."
"The use of recombinant DNA techniques to express proteins in cell culture has been a successful approach for generation of highly effective vaccines for the prevention of hepatitis B virus and human papillomavirus. Among the available expression technologies, recombinant baculovirus is especially well suited for production of influenza vaccine because the rapidity with which genes can be cloned and inserted into this vector facilitates updating the vaccine at regular intervals. In addition, the extraordinarily high yields of protein possible in this system provide the opportunity to use much higher and potentially more effective doses of vaccine. Expression of the HA protein in insect cells using recombinant baculovirus also avoids the need to work with potentially pathogenic live influenza viruses and the attendant biocontainment issues that would be a particular concern for generation of pandemic vaccines. The preliminary demonstration of protective efficacy in adults provides further support for the development of this promising approach for prevention of seasonal and pandemic influenza," the authors conclude.
JAMA and Archives Journals
Influenza Current Events and Influenza News RSSAmid the flu epidemic, don't forget RSV in young children
Influenza, particularly H1N1, has understandably captured the attention of public health officials, the media and the public.
Multiple health concerns surface as winter, vitamin D deficiences arrive
A string of recent discoveries about the multiple health benefits of vitamin D has renewed interest in this multi-purpose nutrient, increased awareness of the huge numbers of people who are deficient in it, spurred research and even led to an appreciation of it as "nature's antibiotic."
Asthma a significant risk factor for complications in children with H1N1
A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu.
Preventing H1N1 spread to health care workers: Dilemma, debate and confusion
A commentary in the December issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen - the influenza virus - and its impact on decisions about how best to protect health care workers.
New culprit for viral infections among elderly -- an overactive immune response
Researchers at Yale School of Medicine have found that exaggerated responses of the immune system explain why the elderly succumb to viral infections more readily than younger people.
New research helps explain why bird flu has not caused a pandemic
Bird flu viruses would have to make at least two simultaneous genetic mutations before they could be transmitted readily from human to human, according to research published today in PLoS ONE.
Mechanical ventilation for patients with lung damage don't always work as planned
As more Canadians are diagnosed with H1N1 influenza infection, some will be admitted to hospital. The most severely affected may be treated in the intensive care unit (ICU) and placed on a mechanical ventilator to help them breathe while they recover from the infection.
Researchers mobilizing global resources to test new treatments for severe H1N1 infection
An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic.
Worksite wellness programs may reduce employee absenteeism
Emory University Rollins School of Public Health researchers will present Nov. 11 on a range of topics at the American Public Health Association's annual meeting in Philadelphia, including a study that found reduced absenteeism among employees participating in a large-scale worksite wellness program.
U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat
Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide.
More Influenza Current Events and Influenza News Articles
 |
The Great Influenza: The story of the deadliest pandemic in history by John M. Barry (Author) At the height of WWI, history’s most lethal influenza virus erupted in an army camp in Kansas, moved east with American troops, then exploded, killing as many as 100 million people worldwide. It killed more people in twenty-four months than AIDS killed in twenty-four years, more in a year than the Black Death killed in a century. But this was not the Middle Ages, and 1918 marked the first collision of science and epidemic disease. Magisterial in its breadth of perspective and depth of research and now revised to reflect the growing danger of the avian flu, The Great Influenza is ultimately a tale of triumph amid tragedy, which provides us with a precise and sobering model as we confront the epidemics looming on our own horizon. John M. Barry has written a new ... |
 |
A Cruel Wind: Pandemic Flu in America 1918-1920 by Dorothy A. Pettit (Author) |
 |
Flu : The Story Of The Great Influenza Pandemic by Gina Kolata (Author) A scientific history of the Great Flu Epidemic of 1918, which killed at least 40 million people. The author details the science and latest understanding of flu, examines the chances of a great epidemic recurring and explores what can be done to prevent it. |
 |
Flu: A Social History of Influenza by Tom Quinn (Author) It may sound innocuous compared to war, plague and famine, but flu is in fact one of the world's biggest killers. Strains of the virus are always in circulation but every so often a new and particularly virulent one comes along, to which we have no historic immunity - when that happens the consequences are devastating. This fascinating book explores the havoc caused by the world's most deadly virus - and the destruction left in its wake. From its initial identification by the Greek physician Hippocrates in the 4th century BC to the Spanish flu pandemic of 1918 and beyond, Tom Quinn explores the social, medical and scientific ramifications of the major outbreaks that have occurred over the centuries - and the potential consequences should such a pandemic occur in the modern world, an event... |
 |
Influenza Virology: Current Topics by Yoshihiro Kawaoka (Author) |
 |
America's Forgotten Pandemic: The Influenza of 1918 by Alfred W. Crosby (Author) Between August 1918 and March 1919 the Spanish influenza spread worldwide, claiming over 25 million lives, more people than those perished in the fighting of the First World War. It proved fatal to at least a half-million Americans. Yet, the Spanish flu pandemic is largely forgotten today. In this vivid narrative, Alfred W. Crosby recounts the course of the pandemic during the panic-stricken months of 1918 and 1919, measures its impact on American society, and probes the curious loss of national memory of this cataclysmic event. In a new edition, with a new preface discussing the recent outbreaks of diseases, including the Asian flu and the SARS epidemic, America's Forgotten Pandemic remains both prescient and relevant. Alfred W. Crosby is a Professor Emeritus in American Studies,... |
 |
American Experience - Influenza 1918 Starring: David McCullough, David Ogden Stiers, Joe Morton, Liev Schreiber, Linda Hunt Also With: Katy Mostoller (Producer), Michael Rossi (Producer), Rocky Collins (Producer), Rocky Collins (Writer), Tracy Heather Strain (Producer), Henry Hampton (Writer) As the nation mobilized for war in the spring of 1918, ailing Private Albert Gitchell reported to an army hospital in Kansas. He was diagnosed with the flu, a disease about which doctors knew little. Before the year was out, America would be ravaged by a flu epidemic that killed 675,000 people--more than died in all the wars of this century combined--before disappearing as mysteriously as it began. |
 |
The Devil's Flu: The World's Deadliest Influenza Epidemic and the Scientific Hunt for the Virus That Caused It by Pete Davies (Author) A gripping account of the 1918 flu pandemic and the modern-day hunt for this elusive and deadly virus In 1918, a flu virus more lethal than any that has come along since swept through the world, from the remotest villages in Arctic climates to crowded U.S.cities to the battlefields of Europe, killing forty million people. Yet, despite its devastating toll and the probability that other deadly pandemics await on the horizon, it was relegated to a footnote in history. The Devil's Flu is the extraordinary story of 1918's forgotten tragedy and of the global scientific community's effort to avert another such disaster. The 1918 flu still so intrigues and frightens experts in the field that in 1998, a group of respected scientists journeyed to the Norwegian Arctic Circle in search... |
 |
Rapid Reference to Influenza by Jan Wilschut (Author), Janet Mcelhaney (Author), Abraham Palache (Author) Provides the reader with authoritative and accessible information on the subject of influenza. Clearly written by key experts in the field and highly illustrated in full colour, the book provides an overview of influenza, its pathogenesis, epidemiology, the burden of disease and its health economics. Rapid Reference Influenza also summarises available information on the molecular biology of influenza and the emergence of new influenza viruses. Completely updated with the latest information on H5N1, the book aims to contribute to international efforts to emphasize the major burden of influenza and the need for better control. * Expert information succinctly written for ease of use. * Abundant use of bulleted lists and short tables, for quick access to comparative information. * Presents... |
 |
Pandemic Influenza: Emergency Planning and Community Preparedness by Jeffrey R. Ryan (Editor) The swine flu emergency needn’t become a crisis. This critically acclaimed work provides public health officials, doctors, responders, and emergency planners with accurate current information that will help them understand the nature of an outbreak, assess risk, answer public concerns, and develop informed strategies. Devoid of sensationalism and agenda, this CRC Press resource provides all the information needed to understand pandemic influenzas including, avian, swine, and human variations and outlines the steps needed to develop and implement prevention, stabilization, and recovery efforts as needed at the local level. ... an amazing resource ... Dr. Ryan has assembled some of the best experts in the field to guide you in understanding... |
| © 2009 BrightSurf.com |